Antiplatelet therapies for the treatment of cardiovascular disease.

Nature Reviews. Drug Discovery
Alan D Michelson

Abstract

Antiplatelet therapy has been successful in reducing mortality and morbidity in acute myocardial infarction. Recent advances in understanding the molecular basis of the role of platelets in cardiovascular thrombosis have enabled the development of new agents with the potential to further reduce mortality and morbidity. This article reviews the role of platelets in haemostasis and cardiovascular thrombosis, and discusses the benefits and limitations of current and investigational antiplatelet agents in the treatment of cardiovascular disease.

References

Aug 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·G J RothP W Majerus
Oct 1, 1974·British Journal of Haematology·A T Nurden, J P Caen
Apr 1, 1997·The Journal of Clinical Investigation·B S Coller
Feb 1, 1997·Cardiovascular Surgery : Official Journal of the International Society for Cardiovascular Surgery·T E BrothersP V Halushka
Aug 25, 2001·The New England Journal of Medicine·S YusufUNKNOWN Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators
Aug 25, 2001·Lancet·S R MehtaUNKNOWN Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators
Nov 19, 2002·JAMA : the Journal of the American Medical Association·Steven R SteinhublUNKNOWN CREDO Investigators. Clopidogrel for the Reduction of Events During Observation
Jan 23, 2003·Prostaglandins, Leukotrienes, and Essential Fatty Acids·J M DognéB Pirotte
Aug 21, 2003·European Surgical Research. Europäische Chirurgische Forschung. Recherches Chirurgicales Européennes·Y ItoM Majima
Oct 16, 2003·The Journal of Pharmacology and Experimental Therapeutics·Na QiaoCecil R Pace-Asciak
Mar 11, 2004·Journal of Thrombosis and Haemostasis : JTH·J I OsendeJ J Badimon
Jun 15, 2004·Journal of the American College of Cardiology·Mark I FurmanAlan D Michelson
Oct 12, 2004·European Heart Journal·Gian Gastone Neri SerneriUNKNOWN Drug Evaluation in Atherosclerotic Vascular Disease in Diabetics (DAVID) Study Group
Nov 30, 2004·Thrombosis Research·Waiel M SamaraPaul A Gurbel
Mar 11, 2005·The New England Journal of Medicine·Marc S SabatineUNKNOWN CLARITY-TIMI 28 Investigators
Apr 27, 2005·Seminars in Thrombosis and Hemostasis·J J J van Giezen, Robert G Humphries
Jun 28, 2005·Journal of Thrombosis and Haemostasis : JTH·P GaussemJ-N Fiessinger
Nov 8, 2005·Lancet·Z M ChenUNKNOWN COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group
Nov 16, 2005·Journal of the American College of Cardiology·Paul A GurbelUdaya S Tantry
Mar 15, 2006·The New England Journal of Medicine·Deepak L BhattUNKNOWN CHARISMA Investigators

❮ Previous
Next ❯

Citations

Oct 12, 2013·Applied Microbiology and Biotechnology·Aiqin JiangJian-Ning Liu
May 15, 2012·Journal of Anesthesia·Emile CalendaMarc Muraine
May 6, 2011·Archives of Pharmacal Research·Sunkyung Lee
Aug 4, 2011·Archives of Pharmacal Research·Jae-Hwan KwakJae-Kyung Jung
Nov 9, 2011·Nature Medicine·Shaun P Jackson
Feb 24, 2012·The Journal of Infectious Diseases·Chiau-Jing JungJean-San Chia
Dec 14, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Elizabeth MayneMichael M Lederman
Aug 13, 2010·Arteriosclerosis, Thrombosis, and Vascular Biology·Gabrielle FredmanCharles N Serhan
Apr 13, 2013·Circulation Research·Kamila BledzkaEdward F Plow
Dec 14, 2011·Hematology·Zane S Kaplan, Shaun P Jackson
Dec 14, 2011·Hematology·Alan D Michelson
Jul 14, 2012·Journal of Blood Medicine·Jennifer Yeung, Michael Holinstat
Apr 12, 2014·Theranostics·Amanda Karine Andriola SilvaCédric Chauvierre
Jun 28, 2014·PloS One·Lewis TaylorCarmen H Coxon
Mar 28, 2013·Case Reports in Oncological Medicine·Kyriakos NeofytouAthanasios Petrou
Jul 19, 2014·European Journal of Medicinal Chemistry·Carmen B RödlBettina Hofmann
Jul 16, 2014·Seminars in Oncology·MengJie YanPaul Jurasz
Sep 23, 2014·The Journal of Clinical Investigation·Shaojing YeSidney W Whiteheart
Oct 9, 2014·Advances in Surgery·Prakash A Patel, Lee A Fleisher
May 25, 2013·Circulation Research·Matthew T RondinaGuy A Zimmerman
Oct 26, 2012·Critical Reviews in Clinical Laboratory Sciences·Matthew D Linden, Huyen A Tran
Oct 23, 2010·Expert Review of Molecular Diagnostics·Lourdes Basabe-DesmontsDermot Kenny
Oct 13, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Leandro Augusto RossetoJean Leandro Dos Santos
Oct 9, 2014·International Journal of Molecular Sciences·Reinaldo Barros GeraldoHelena Carla Castro
Aug 30, 2013·Expert Review of Cardiovascular Therapy·Sabine Steiner, Deddo Moertl
Jan 29, 2016·Biologie aujourd'hui·Mathieu SchaffPierre Henri Mangin
May 7, 2015·Proceedings of the National Academy of Sciences of the United States of America·Vasudharani DevanathanBernd Nürnberg
Jan 26, 2016·European Journal of Medicinal Chemistry·Ankita MisraDinesh K Dikshit
Aug 21, 2012·Trends in Pharmacological Sciences·Sebastian DüttingBernhard Nieswandt
May 1, 2012·Nanomedicine : Nanotechnology, Biology, and Medicine·Gianni F GuidettiMauro Torti
Jan 1, 2011·Trends in Cardiovascular Medicine·Jorge MagallonThomas G Diacovo
May 2, 2012·Bioorganic & Medicinal Chemistry Letters·Hao ZhangHongbin Sun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.